Management Credibility Analysis
Upcoming Catalysts
Verified event feedCompany profile
No description available
- Chief executive
- Not disclosed
- Headquarters
- 3M CENTER, ST PAUL, MN
- Founded
- Not disclosed
📈 Company Timeline
3M Company filed Form 10-Q
3M Company submitted Form 10-Q to the SEC for the period ending Sep 30, 2026.
3M Company reported Operating or financial results
3M Company filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
3M Company reported Regulation FD disclosure
3M Company filed an 8-K covering Regulation FD disclosure.
Large-holder ownership filing
A holder reported or amended a beneficial ownership position of more than 5% in 3M Company.
3M Company reported Another company event
3M Company filed an 8-K covering another company event, supporting financial statements or exhibits.
Capital Structure & Financial Position
Financial strength and liquidity analysisSource: SEC EDGAR company facts (opens in a new tab) Balance sheet dated
Peer Comparison - Health Care
| Company | Price | Market Cap |
|---|---|---|
| LLY - Eli Lilly and Company |
$1,276.13
Yahoo Finance |
$1.20T |
| JNJ - Johnson & Johnson |
$256.74
Yahoo Finance |
$618.71B |
| ABBV - AbbVie Inc. |
$284.80
Yahoo Finance |
$503.28B |
| UNH - UnitedHealth Group Incorporated |
$418.43
Yahoo Finance |
$375.58B |
| MRK - Merck & Co., Inc. |
$148.55
Yahoo Finance |
$366.50B |
📋 Corporate Actions
Recent and upcoming corporate eventsFinancials
Financial statements and key metrics analysis| Quarter | Revenue (USD) | Operating income | Net income | Diluted EPS (USD) | Filed |
|---|---|---|---|---|---|
| Q3 2026 | $6.58B | $1.56B | $1.37B | $2.63 | 10-Q · 20 Oct 2026 |
| Q2 2026 | $6.50B | $984.00M | $933.00M | $1.78 | 10-Q · 21 Jul 2026 |
| Q1 2026 | $6.03B | $1.40B | $653.00M | $1.23 | 10-Q · 21 Apr 2026 |
| Q4 2025 | $6.13B | $796.00M | $577.00M | Unavailable | 10-K · 3 Feb 2026 |
| Q3 2025 | $6.52B | $1.45B | $834.00M | $1.55 | 10-Q · 21 Oct 2025 |
| Q2 2025 | $6.34B | $1.14B | $723.00M | $1.34 | 10-Q · 18 Jul 2025 |
Analyst Consensus
Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 135.00–218.00 Ratings are third-party opinions, not advice.
💰 Upcoming Dividends
Next dividend paymentsGuidance Evolution
💼 Director Transactions
Recent insider activityTop Shareholders
Source: Nasdaq institutional holdings (opens in a new tab) Observed · 9 hours ago